Small Molecule Inhibits OmpV to Fight Cholera
In a groundbreaking development poised to transform the treatment of cholera pandemics, researchers have unveiled a novel small molecule inhibitor...
Iris M. reports on pharmacology and drug discovery, tracking therapeutic targets, preclinical findings, clinical candidates, safety signals, and new treatment strategies.
In a groundbreaking development poised to transform the treatment of cholera pandemics, researchers have unveiled a novel small molecule inhibitor...
In recent years, the field of drug delivery has witnessed significant advancements, particularly with the integration of nanotechnology and innovative...
In the realm of pediatric healthcare, the importance of imaging techniques cannot be overstated. These methods serve as crucial tools...
In recent years, a remarkable evolution has taken place in the field of cardiology, ushering in a new era of...
In the ever-evolving world of biomedical engineering, researchers are constantly seeking innovative solutions to some of healthcare's most pressing challenges....
In recent scientific advancements, the exploration of novel therapeutic strategies to combat acute respiratory distress syndrome (ARDS) has gained formidable...
Recent research has highlighted a significant relationship between the daily dosage of dipeptidyl peptidase-4 (DPP-4) inhibitors and the variations in...
In recent years, the intersection of nanotechnology and pharmacology has emerged as a beacon of hope in the battle against...
In an era where education technology continually evolves, the impact of reflective practices on learning outcomes is receiving renewed interest,...
In the pursuit of advancing treatments for type 2 diabetes, researchers have made significant strides in developing novel molecules that...
Ā© 2025 Scienmag - Science Magazine
Ā© 2025 Scienmag - Science Magazine